Inozyme Pharma

Scroll
Investment area
Novo Ventures
Region
Eastern USA
Date of investment
January 2017
Website
https://www.inozyme.com/

Inozyme Pharmaceuticals develops enzyme replacement therapies to treat orphan diseases characterized by aberrant calcification as a result of inorganic pyrophosphate (PPi) deficiency.